Showing 1 - 8 results of 8 for search 'Michele Cavo', query time: 0.02s Refine Results
  1. 1
    Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient

    Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient by Pier Luigi Zinzani, Ginevra Lolli, Beatrice Casadei, Lisa Argnani, Laura Nanni, Michele Cavo

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an In Vitro Antileukemic Immune Response

    PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an In Vitro Antileukemic Immune Response by Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michele Cavo, Darina Očadlíková, Roberto M. Lemoli, Antonio Curti

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients

    Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients by Valentina Salvestrini, Gabriele Conti, Federica D'Amico, Gianluca Cristiano, Marco Candela, Michele Cavo, Silvia Turroni, Antonio Curti

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly

    Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly by Daria Sollazzo, Dorian Forte, Nicola Polverelli, Margherita Perricone, Marco Romano, Simona Luatti, Nicola Vianelli, Michele Cavo, Francesca Palandri, Lucia Catani

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34+ Cells

    Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34+ Cells by Dorian Forte, Daria Sollazzo, Martina Barone, Marisole Allegri, Angela di Martella Orsi, Marco Romano, Barbara Sinigaglia, Giuseppe Auteri, Nicola Vianelli, Michele Cavo, Francesca Palandri, Lucia Catani

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial

    Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial by Salomon Manier, Meletios-Athanasios Dimopoulos, Xavier P. Leleu, Philippe Moreau, Michele Cavo, Hartmut Goldschmidt, Robert Z. Orlowski, Muriel Tron, Christina Tekle, Marie-France Brégeault, Andrea T. Shafer, Meral Beksac, Thierry Facon

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    SETD2 loss of function is a recurrent event in advanced‐phase chronic myeloid leukemia and contributes to genomic instability

    SETD2 loss of function is a recurrent event in advanced‐phase chronic myeloid leukemia and contributes to genomic instability by Manuela Mancini, Sara De Santis, Cecilia Monaldi, Fausto Castagnetti, Miriam Iezza, Alessandra Iurlo, Daniele Cattaneo, Sara Galimberti, Marco Cerrano, Isabella Capodanno, Massimiliano Bonifacio, Maura Rossi, Claudio Agostinelli, Manja Meggendorfer, Torsten Haferlach, Michele Cavo, Gabriele Gugliotta, Simona Soverini

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma

    Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma by Andrea Poletti, Barbara Taurisano, Gaia Mazzocchetti, Marta Lionetti, Marina Martello, Viola Meixian Vuong, Vincenza Solli, Giulia Marzocchi, Akihiro Maeda, Ilaria Vigliotta, Enrica Borsi, Silvia Armuzzi, Ignazia Pistis, Alessio Marella, Sonia Fabris, Paola Tacchetti, Katia Mancuso, Ilaria Rizzello, Lucia Pantani, Nicoletta Testoni, Michele Cavo, Elena Zamagni, Niccolò Bolli, Carolina Terragna

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: